R

Read Gene SA
WSE:RDG

Watchlist Manager
Read Gene SA
WSE:RDG
Watchlist
Price: 4.95 PLN -0.2% Market Closed
Market Cap: 58.4m PLN
Have any thoughts about
Read Gene SA?
Write Note

Read Gene SA
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Read Gene SA
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
R
Read Gene SA
WSE:RDG
Short-Term Investments
zł4.4m
CAGR 3-Years
-13%
CAGR 5-Years
2%
CAGR 10-Years
84%
M
Mabion SA
WSE:MAB
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genomed SA
WSE:GEN
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
U
Urteste SA
WSE:URT
Short-Term Investments
zł23.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Read Gene SA
Glance View

Market Cap
58.4m PLN
Industry
Biotechnology

Read-Gene SA engages in the medical research and testing. The company is headquartered in Szczecin, Woj. Zachodniopomorskie. The company went IPO on 2009-02-12. The company is focused on technologies which aim is to detect, prevent and treat malignant tumors. The firm specializes in three fields: chemoprevention, clinical trials and genetic testing. The company offers breast cancer, colon cancer and prostate cancer tests, as well as, medical consultancy, DNA tests and supplements. The firm operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o. Its major shareholder is GEN-PAT-MED Sp. z o.o.

RDG Intrinsic Value
2.52 PLN
Overvaluation 49%
Intrinsic Value
Price
R

See Also

What is Read Gene SA's Short-Term Investments?
Short-Term Investments
4.4m PLN

Based on the financial report for Jun 30, 2024, Read Gene SA's Short-Term Investments amounts to 4.4m PLN.

What is Read Gene SA's Short-Term Investments growth rate?
Short-Term Investments CAGR 10Y
84%

Over the last year, the Short-Term Investments growth was -34%. The average annual Short-Term Investments growth rates for Read Gene SA have been -13% over the past three years , 2% over the past five years , and 84% over the past ten years .

Back to Top